Epidemiology of cardio-renal syndromes: workgroup statements from the 7th ADQI Consensus Conference
Sean M. Bagshaw(University of Alberta), Inder S. Anand(University of Minnesota), Peter A. McCullough(Providence Hospital), G. Sheinfeld(University of Maryland, College Park), Rinaldo Bellomo(Austin Health), Ilona Bobek, Sachin Soni(MaxCure Hospitals), Andrew Shaw, Piotr Ponikowski(Wroclaw Medical University), Nadia Aspromonte(Agostino Gemelli University Polyclinic), Mikko Haapio(Helsinki University Hospital), Tomás Berl(University of Colorado Health), Giorgio Vescovo(Ospedale San Bortolo), Sunil Mankad(Mayo Clinic in Arizona), Hans L. Hillege(University Medical Center Groningen), Alberto Palazzuoli, Alan S. Maisel(University of California San Diego Medical Center), Luciano Daliento(University of Padua), Nereo Zamperetti(Ospedale San Bortolo), Andrew A. House(Western University), Claudio Ronco(International Renal Research Institute of Vicenza), Alexandre Mebazaa, P. Zanco(Ospedale San Bortolo), Federico Ronco(University of Padua), Andrew Davenport(Royal Free London NHS Foundation Trust), D. N. Cruz(Ospedale San Bortolo), Stefan D. Anker(German Centre for Cardiovascular Research), N. Katz(George Washington University)
Cited by 231
Related Papers
Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease
|New England Journal of Medicine|2017|9.1k
Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction
|New England Journal of Medicine|2019|6.8k
Acute renal failure – definition, outcome measures, animal models, fluid therapy and information technology needs: the Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group
|Critical Care|2004|6.8k
2016 ESC Guidelines for the Diagnosis and Treatment of Acute and Chronic Heart Failure
|European Journal of Heart Failure|2016|5.9k
Empagliflozin in Heart Failure with a Preserved Ejection Fraction
|New England Journal of Medicine|2021|4.6k